CP-91149

• Description:

  CP-91149 is a GP (glycogen phosphorylase) inhibitor. CP-91149 promotes glycogen resynthesis, but not its overaccumulation. CP-91149 has the potential for Type II (insulin-dependent) diabetes study[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Biochemical Assay Reagents

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Cancer; Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/cp-91149.html

• Purity:

  99.86

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C (C (N1) =CC2=C1C=CC (Cl) =C2) N[C@@H] (CC3=CC=CC=C3) [C@@H] (O) C (N (C) C) =O

• Molecular Formula:

  C21H22ClN3O3

• Molecular Weight:

  399.88

• Precautions:

  H302

• References & Citations:

  [1]Carlos Lerín, et al. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149. 2004 Mar 15; 378 (Pt 3) : 1073–1077.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  186392-40-5